Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)
Stock-Based Compensation
$40.00M
Quarterly · Period ending: · USD
TEVA Stock-Based Compensation
Latest reported$40.00Mperiod ending
Latest reported$40.00Mperiod ending
TEVA Quarterly Stock-Based Comp ($0.00 → $40.00M)
Quarterly stock-based compensation
High-resolution chart · PNG
TEVA stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 40,000,000 | |
| 43,000,000 | |
| 51,000,000 | |
| 34,000,000 | |
| 38,000,000 | |
| 34,000,000 | |
| 34,000,000 | |
| 29,000,000 | |
| 32,000,000 | |
| 28,000,000 | |
| 28,000,000 | |
| 31,000,000 | |
| 30,000,000 | |
| 32,000,000 | |
| 36,000,000 | |
| 26,000,000 | |
| 39,000,000 | |
| 24,000,000 | |
| 33,000,000 | |
| 26,000,000 | |
| 29,000,000 | |
| 31,000,000 | |
| 38,000,000 | |
| 29,000,000 | |
| 32,000,000 | |
| 30,000,000 | |
| 20,000,000 | |
| 35,000,000 | |
| 30,000,000 | |
| 34,000,000 | |
| 33,000,000 | |
| 45,000,000 | |
| 47,000,000 | |
| 30,000,000 | |
| 27,000,000 | |
| 31,000,000 | |
| 35,000,000 | |
| 40,000,000 | |
| 41,000,000 | |
| 31,000,000 | |
| 28,000,000 | |
| 24,000,000 | |
| 31,000,000 | |
| 26,000,000 | |
| 31,000,000 | |
| 29,000,000 | |
| 34,000,000 | |
| 18,000,000 | |
| 26,000,000 | |
| 17,000,000 | |
| 22,000,000 | |
| 17,000,000 | |
| 7,000,000 | |
| 18,000,000 | |
| 21,000,000 | |
| 20,000,000 | |
| 21,000,000 | |
| 20,000,000 | |
| 22,000,000 | |
| 22,000,000 | |
| 24,000,000 | |
| 23,000,000 | |
| 21,000,000 | |
| 18,000,000 | |
| 23,000,000 | |
| 18,000,000 | |
| 38,000,000 | |
| 16,000,000 | |
| 16,000,000 | |
| 9,000,000 | |
| -29,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 63,400,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 33,000,000 | |
| 0 |